As the most reliable and balanced news aggregation service on the internet, DML News offers the following information published by TheHill.com:
Sen. Cory Booker (D-N.J.) is trying to overcome doubts that he is too close to the pharmaceutical industry ahead of an expected presidential campaign.
The progressive criticism of Booker reached a crescendo in early 2017 when he voted against a budget amendment calling for importing drugs from abroad.
The article goes on to state the following:
The line of attack played into broader fears from progressives that Booker is not tough enough on corporations in general, including Wall Street.
But on Thursday, Booker attempted to show he is tough on drug companies, appearing alongside socialist Sen. Bernie Sanders (I-Vt.), a potential presidential rival, at a press conference on lowering drug prices.
Booker spoke out in strong terms against drug companies and the “outrageous and unjustifiably high cost of prescription drugs.”
— The Hill (@thehill) January 14, 2019
Booker tries to shake doubts about pharmaceutical ties ahead of 2020 – https://t.co/TTQQT4iDWQ
— Joe Concha (@JoeConchaTV) January 14, 2019
Right now 1 in 5 Americans cannot afford their prescription drugs – an unacceptable statistic. No American should have to ration medication, cut pills in half, or choose between food or life-saving treatment.
We introduced 3 bills today to fix the problem. pic.twitter.com/lFZRlRY5SG
— Cory Booker (@CoryBooker) January 11, 2019
To get more information about this article, please visit TheHill.com. To weigh in, leave a comment below.